BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36608470)

  • 1. Fludrocortisone evaluation in aneurysmal subarachnoid hemorrhage patients with cerebral salt wasting (Flush Salt).
    Elledge SR; Shewmaker JW; Yang S; Blunck JR
    Clin Neurol Neurosurg; 2023 Feb; 225():107568. PubMed ID: 36608470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early inhibition of natriuresis suppresses symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Nakagawa I; Hironaka Y; Nishimura F; Takeshima Y; Matsuda R; Yamada S; Motoyama Y; Park YS; Nakase H
    Cerebrovasc Dis; 2013; 35(2):131-7. PubMed ID: 23406891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fludrocortisone in the treatment of subarachnoid hemorrhage-induced hyponatremia.
    Woo MH; Kale-Pradhan PB
    Ann Pharmacother; 1997 May; 31(5):637-9. PubMed ID: 9161663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of cerebral salt wasting with fludrocortisone in a child with lissencephaly.
    Ozdemir H; Aycan Z; Degerliyurt A; Metin A
    Turk Neurosurg; 2010 Jan; 20(1):100-2. PubMed ID: 20066633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludrocortisone therapy in cerebral salt wasting.
    Taplin CE; Cowell CT; Silink M; Ambler GR
    Pediatrics; 2006 Dec; 118(6):e1904-8. PubMed ID: 17101713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hyponatremia and volume contraction.
    Rabinstein AA; Bruder N
    Neurocrit Care; 2011 Sep; 15(2):354-60. PubMed ID: 21748503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage.
    Wijdicks EF; Vermeulen M; van Brummelen P; van Gijn J
    Clin Neurol Neurosurg; 1988; 90(3):209-14. PubMed ID: 3197346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased urinary sodium excretion in the early phase of aneurysmal subarachnoid hemorrhage as a predictor of cerebral salt wasting syndrome].
    Nakagawa I; Kurokawa S; Takayama K; Wada T; Nakase H
    Brain Nerve; 2009 Dec; 61(12):1419-23. PubMed ID: 20034309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A challenging coexistence of central diabetes insipidus and cerebral salt wasting syndrome: a case report.
    Costa MM; Esteves C; Castedo JL; Pereira J; Carvalho D
    J Med Case Rep; 2018 Jul; 12(1):212. PubMed ID: 30012213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage.
    Mori T; Katayama Y; Kawamata T; Hirayama T
    J Neurosurg; 1999 Dec; 91(6):947-52. PubMed ID: 10584839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Fludrocortisone in the Treatment of Cerebral Salt Wasting in Patients With Tuberculous Meningitis: A Randomized Clinical Trial.
    Misra UK; Kalita J; Kumar M
    JAMA Neurol; 2018 Nov; 75(11):1383-1391. PubMed ID: 30105362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of fludrocortisone in a child with cerebral salt wasting.
    Sakarcan A; Bocchini J
    Pediatr Nephrol; 1998 Nov; 12(9):769-71. PubMed ID: 9874324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral salt-wasting syndrome in a child with Wernicke encephalopathy treated with fludrocortisone therapy: A case report.
    Han MJ; Kim SC; Joo CU; Kim SJ
    Medicine (Baltimore); 2016 Sep; 95(36):e4393. PubMed ID: 27603336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral salt wasting treated with fludrocortisone in a 17-year-old boy.
    Choi MJ; Oh YS; Park SJ; Kim JH; Shin JI
    Yonsei Med J; 2012 Jul; 53(4):859-62. PubMed ID: 22665358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage.
    Kao L; Al-Lawati Z; Vavao J; Steinberg GK; Katznelson L
    Pituitary; 2009; 12(4):347-51. PubMed ID: 19462244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hyponatremia after aneurysmal subarachnoid hemorrhage: Frequency, treatment, and outcome.
    Kieninger M; Kerscher C; Bründl E; Bele S; Proescholdt M; Zeman F; Graf B; Schmidt NO; Schebesch KM
    J Clin Neurosci; 2021 Jun; 88():237-242. PubMed ID: 33992191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of arginine vasopressin and renal sodium handling in pathogenesis of hyponatremia in elderly patients.
    Ishikawa S; Fujita N; Fujisawa G; Tsuboi Y; Sakuma N; Okada K; Saito T
    Endocr J; 1996 Feb; 43(1):101-8. PubMed ID: 8732459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids in the Management of Hyponatremia, Hypovolemia, and Vasospasm in Subarachnoid Hemorrhage: A Meta-Analysis.
    Mistry AM; Mistry EA; Ganesh Kumar N; Froehler MT; Fusco MR; Chitale RV
    Cerebrovasc Dis; 2016; 42(3-4):263-71. PubMed ID: 27173669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage.
    Hasan D; Lindsay KW; Wijdicks EF; Murray GD; Brouwers PJ; Bakker WH; van Gijn J; Vermeulen M
    Stroke; 1989 Sep; 20(9):1156-61. PubMed ID: 2672426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral salt wasting syndrome in patients with aneurysmal subarachnoid hemorrhage.
    Revilla-Pacheco FR; Herrada-Pineda T; Loyo-Varela M; Modiano-Esquenazi M
    Neurol Res; 2005 Jun; 27(4):418-22. PubMed ID: 15949241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.